Internet Use Among Women With Recurrent Metastatic Breast Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00770055|
Recruitment Status : Completed
First Posted : October 9, 2008
Last Update Posted : January 31, 2011
RATIONALE: Gathering information about patients with breast cancer over time may help doctors learn more about a patient's use of the internet to find information about treatment, symptom management, and emotional support.
PURPOSE: This clinical trial is studying internet use among women with recurrent metastatic breast cancer.
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer||Other: medical chart review Other: questionnaire administration Other: survey administration Procedure: psychosocial assessment and care||Not Applicable|
- To document the proportion of women who use the internet to access treatment and symptom management information and to seek emotional support after diagnosis of metastatic recurrent breast cancer.
- To evaluate the association of treatment stage and effectiveness with internet use.
- To evaluate the association of individual differences in patients' demographics, beliefs, emotional functioning, and social and professional support with internet use.
- To evaluate the association of patients' use of the internet to seek resources with their beliefs, emotional functioning, and relationship functioning.
OUTLINE: Patients undergo assessments consisting of paper and pencil questionnaires at four time points. The timing of these assessments is linked to the patient's treatment course and her presumed need to access internet resources for information on cancer, treatment, symptom management, and emotional support. Patients who discontinue regular care at the Cancer Institute of New Jersey site during the course of the study may complete study assessments through phone interviews conducted by a member of the study team.
Patients undergo a baseline survey prior to deciding on a treatment course for their newly progressive disease. Patients complete the first part of the survey to provide information on demographics, beliefs about cancer, mood states, somatic symptoms, and available resources for cancer information and emotional support. Patients complete the second part of the survey, if they have used the internet previously to obtain information and resources about cancer or if they have received cancer information that someone else located on the internet for them, which inquires about patients' internet use, any internet resources they have received from family members, friends, or other people they know, and their own evaluation of these internet resources. Patients undergo the second study assessment after completion of the first course of treatment and prior to initiating course 2 (i.e., 3 to 4 weeks after initiating treatment). The third study assessment occurs within the first 2 weeks after the medical oncologist's first evaluation of treatment response (i.e., 6-9 weeks after initiating treatment). The fourth assessment occurs after the medical oncologist's second evaluation of the patient's response to treatment, following tumor re-staging.
Patients complete several questionnaires during these assessments to provide information about personal characteristics (demographics, physical and psychological well-being, beliefs about cancer and treatment, optimism), social and healthcare networks (perceived social support, social network composition, beliefs about treatment team), and outcomes (use of non-internet cancer information, use of the internet for cancer resources, use of interactive technologies, communication with treatment team and family, evaluation of internet resources).
The following information is extracted from the patients' medical record: stage and node status at primary diagnosis, previous oncology surgeries, previous adjuvant treatments, current menopausal status, treatment at time of recurrence, disease free interval, site(s) of metastasis, and response to current treatment.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||70 participants|
|Primary Purpose:||Health Services Research|
|Official Title:||Internet Use Among Women With Recurrent Breast Cancer|
|Study Start Date :||November 2001|
|Actual Primary Completion Date :||February 2010|
|Actual Study Completion Date :||January 2011|
- Use of non-internet cancer information
- Use of the internet for cancer resources
- Use of interactive technologies
- Communication with treatment team and family members
- Evaluation of internet resources
- Changes in internet use over the course of treatment
- Cross-sectional associations between patients' internet use and their individual, social, and professional network characteristics
- Internet use and changes in patients' beliefs and emotional functioning
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00770055
|United States, New Jersey|
|Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School|
|New Brunswick, New Jersey, United States, 08903|
|Principal Investigator:||Deborah Toppmeyer, MD||Rutgers Cancer Institute of New Jersey|